临床药师参与1例罕见抗合成酶抗体综合征病例的治疗Pharmaceutical care for a patient with anti-synthase antibody syndrome
项蓓,张婧娴,邓大明,潘慧婕,侯玉婷,唐小蓉,沈杰
摘要(Abstract)：
临床药师参与1例抗合成酶抗体综合征累及多器官合并肺部及软组织感染患者的治疗及药学监护过程,结合患者肝功能损伤,长期处于免疫抑制状态等具体情况与临床医师一起参与用药方案的讨论和制订,同时对患者进行用药宣教,保证了临床用药的合理性和患者用药的安全性。
关键词(KeyWords)： 临床药师;抗合成酶抗体综合征;药学服务
基金项目(Foundation): 上海市长宁区科学技术委员会-临床药学(No.CNKW2016Y11)
作者(Author): 项蓓,张婧娴,邓大明,潘慧婕,侯玉婷,唐小蓉,沈杰
参考文献(References)：
- [1] Lazarou IN,Guerne PA.Classification,diagnosis,and management of idiopathic inflammatory myopathies [J].J Rheumatol,2013,40(5):550-564.
- [2] 赵雪,陈奇,周桂华.伴有血清酶活性升高肝功能异常类肌炎的预警研究[J].中国医药指南,2018,16(27):110-111.
- [3] FDA.FDA Drug Safety Communication:New boxed warning for severe liver injury with arthritis drug Arava(leflunonmide)[EB/OL](2010-07-13)[2010-08-20].
- [4] 周海霞,冯玉麟.免疫抑制患者的肺部感染[J].中国呼吸与危重监护杂志,2014,13(4):423-426.
- [5] Fasano S,Gordon P,Hajji R,et al.Rituximab in the treatment of inflammatory myopathies:A review [J].J Rheumatol,2017,56(1):26-36.
- [6] Kalluri M,Oddis CV.Pulmonary manifestations of the idiopathic inflammatory myopathies [J].Clin Chest Med,2010,31(3):501-512.
- [7] Katzap E,Barilla-LaBarca ML,Marder G.Antisynthetase syndrome [J].Curr Rheumatol Rep,2011,13(3):175-181.
- [8] Liu D,Ahmet A,Ward L,et al.A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy [J].Allergy Asthma Cl Im,2013,9(1):30.
- [9] Klein IH,Abrahams A,van Ede T,et al.Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects [J].Transplantation,2002,73(5):732-736.
- [10] 唐霄,张翠欣,王伟霞.他克莫司的药代动力学特点及其影响因素新进展[J].天津药学,2019,31(3):63-68.
- [11] Sikma MA,Van Maarseveen EM,Van D,et al.Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation [J].Am J Transplant,2015,15(9):2301-2313.
- [12] Vananuvat P,Suwannalai P,Sungkanuparph S,et al.Primary prophylaxis for pneumocystis jirovecii pneumonia in patients with connective tissue diseases [J].Semin Arthritis Rheum,2011,41(3):497-502.